Literature DB >> 9232936

The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.

M Yoshihara1, K Sumii, K Haruma, K Kiyohira, N Hattori, S Tanaka, G Kajiyama, T Shigenobu.   

Abstract

Chronic atrophic gastritis, which is though to be a high risk for gastric cancer, can be diagnosed by serum pepsinogen levels. We compared the usefulness of the measurement of pepsinogen levels and indirect photofluorography as indicators of gastric cancer in a mass screening involving 5,620 Japanese subjects (mean age: 60.1 years old; male : female = 2,268:3,352) in 1991 and 1992. Subjects with a serum pepsinogen I level below 30 micrograms/liter or a pepsinogen I/II ratio below 2.0 were considered to be at high risk of gastric cancer. The incidence of gastric cancer and the ratio of early cancers detected by pepsinogen levels (0.12%, 4/7) were similar to those detected by photofluorography (0.11%, 4/6). Our results showed that mass screening using pepsinogen levels was as useful as indirect photofluorography for the detection of gastric cancer in Japan. In addition, our results showed that the sensitivity of gastric mass screening was increased when the measurement of serum pepsinogen levels was combined with photofluorography.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232936

Source DB:  PubMed          Journal:  Hiroshima J Med Sci        ISSN: 0018-2052


  6 in total

1.  Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.

Authors:  Shigeto Mizuno; Masao Kobayashi; Shohken Tomita; Ikuya Miki; Atsuhiro Masuda; Mitsuko Onoyama; Yasuki Habu; Hideto Inokuchi; Yoshiyuki Watanabe
Journal:  Gastric Cancer       Date:  2009-11-05       Impact factor: 7.370

2.  Simultaneous detection of different serum pepsinogens and its primary application.

Authors:  Jue Zhang; Ji-Zhong Guo; Hua-Long Xiao; Lan Zhu; Hai-Yan Liu; Yi Zhang; Biao Huang
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

3.  Novel risk markers for gastric cancer screening: Present status and future prospects.

Authors:  Shotaro Enomoto; Takao Maekita; Hiroshi Ohata; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2010-12-16

4.  Reduction in serum pepsinogen I after Roux-en-Y gastric bypass.

Authors:  Magnus Sundbom; Erik Mårdh; Sven Mårdh; Margareta Ohrvall; Sven Gustavsson
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

5.  The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.

Authors:  Wei Juan Cai; Liang Yin; Qiang Kang; Zu Chen Zeng; Shao Liang Wang; Jiang Cheng
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

6.  Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.

Authors:  Zhigang Huang; Xie Zhang; Hongna Lu; Lina Wu; Danping Wang; Qiubo Zhang; Huaxin Ding
Journal:  BMC Gastroenterol       Date:  2014-04-11       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.